SCHEMBL27844363

SCHEMBL27844363

[CH2]CC(n1ccc2cnc(Nc3cccc(CN4CCOCC4)c3)nc21)C1(C(=O)O)CCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TBK1 Q9UHD2 7/20 0.55
▸ JAK3 P52333 3/20 0.49
▸ EGFR P00533 2/20 0.47
▸ CDK1 P06493 1/20 0.46
▸ KDR P35968 1/20 0.46
▸ ULK1 O75385 2/20 0.46
▸ ULK2 Q8IYT8 2/20 0.46
▸ NUAK1 O60285 2/20 0.46
▸ IKBKE Q14164 2/20 0.46
▸ MARK3 P27448 2/20 0.46
▸ MARK4 Q96L34 2/20 0.46
▸ STK17A Q9UEE5 2/20 0.46
▸ PRKAA2 P54646 1/20 0.46
▸ SIK1 P57059 1/20 0.46
▸ PRKAA1 Q13131 1/20 0.46
▸ MELK Q14680 1/20 0.46
▸ PDK1 Q15118 1/20 0.46
▸ MARK2 Q7KZI7 1/20 0.46
▸ NUAK2 Q9H093 1/20 0.46
▸ SIK2 Q9H0K1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27844447 0.93 AURKA (0.47) TBK1JAK3EGFRCDK1KDR
SCHEMBL1284581 0.92 TBK1 (0.54) TBK1JAK3EGFRCDK1KDR
SCHEMBL1284997 0.85 TBK1 (0.47) TBK1JAK3EGFRCDK1KDR
SCHEMBL1285268 0.85 AURKA (0.46) TBK1JAK3EGFRCDK1KDR
SCHEMBL27825347 0.83 CDK4 (0.46) TBK1JAK3EGFRCDK1KDR
SCHEMBL27825349 0.83 MAP3K5 (0.47) JAK3EGFRAURKACDK4
SCHEMBL28793682 0.82 CDK4 (0.46) TBK1JAK3EGFRCDK1KDR
SCHEMBL28793684 0.81 MAP3K5 (0.47) JAK3EGFRAURKACDK4
SCHEMBL1284577 0.80 HDAC3 (0.47) TBK1JAK3EGFRCDK2CCNA2
SCHEMBL28793685 0.78 AURKA (0.39) TBK1JAK3EGFRCDK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102341400-A Pyrrolopyrimidines useful as kinase inhibitors MEDICAL RES COUNCIL TECHNOLOGY 2012-02-01 — — CN claimed
CN-102341400-A Pyrrolopyrimidines useful as kinase inhibitors MEDICAL RES COUNCIL TECHNOLOGY 2012-02-01 — — CN disclosed
Send feedback